EpCAM — Drug Target
All drugs that target EpCAM — marketed and clinical-stage. Includes 1 drug classes acting on this target.
Drug classes
Monoclonal antibody, Chemotherapy
Phase 2 pipeline (1)
- Adecatumumab and FOLFOX · Amgen Research (Munich) GmbH · Monoclonal antibody, Chemotherapy · Oncology
Adecatumumab is a monoclonal antibody targeting EpCAM, while FOLFOX is a chemotherapy regimen combining oxaliplatin, 5-fluorouracil, and leucovorin.